Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
More recently, tirzepatide (Mounjaro), approved in 2022, expanded the therapeutic concept further by combining GLP-1 activity with glucose-dependent insulinotropic polypeptide (GIP) receptor agonism
Since it influences cellular metabolism, women should consult a healthcare professional before starting supplementation, especially if they are pregnant, nursing, or managing medical conditions
Before changing your schedule permanently, speak your health care provider
Tirzepatide works as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, primarily to regulate blood sugar levels
Zorrilla JG, Rial C, Cabrera D et al (2021) Pharmacological activities of aminophenoxazinones
US$ 25.27
US$ 21.30
US$ 25.96
US$ 26.21
